Natural history of infants with non-SCID T cell lymphopenia identified on newborn screen
Copyright © 2022 Elsevier Inc. All rights reserved.
Veröffentlicht in: | Clinical immunology (Orlando, Fla.). - 1999. - 245(2022) vom: 10. Dez., Seite 109182 |
---|---|
1. Verfasser: | |
Weitere Verfasser: | , , , , , , , , , , , , , |
Format: | Online-Aufsatz |
Sprache: | English |
Veröffentlicht: |
2022
|
Zugriff auf das übergeordnete Werk: | Clinical immunology (Orlando, Fla.) |
Schlagworte: | Journal Article Genetic testing Newborn screening (NBS) Pneumocystis jirovecii pneumonia (PJP) Severe combined immunodeficiency (SCID) T cell lymphopenia (TCL) T cell receptor excision circle (TREC) Varicella-zoster virus (VZV) |
Zusammenfassung: | Copyright © 2022 Elsevier Inc. All rights reserved. Newborn screening (NBS) for severe combined immunodeficiency (SCID) can identify infants with non-SCID T cell lymphopenia (TCL). The purpose of this study was to characterize the natural history and genetic findings of infants with non-SCID TCL identified on NBS. We analyzed data from 80 infants with non-SCID TCL in the mid-Atlantic region between 2012 and 2019. 66 patients underwent genetic testing and 41 (51%) had identified genetic variant(s). The most common genetic variants were thymic defects (33%), defects with unknown mechanisms (12%) and bone marrow production defects (5%). The genetic cohort had significantly lower median initial CD3+, CD4+, CD8+ and CD4/CD45RA+ T cell counts compared to the non-genetic cohort. Thirty-six (45%) had either viral, bacterial, or fungal infection; only one patient had an opportunistic infection (vaccine strain VZV infection). Twenty-six (31%) of patients had resolution of TCL during the study period |
---|---|
Beschreibung: | Date Completed 25.11.2022 Date Revised 02.12.2023 published: Print-Electronic Citation Status MEDLINE |
ISSN: | 1521-7035 |
DOI: | 10.1016/j.clim.2022.109182 |